Replies to post #333835 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I believe something new is developing. After NWBio releases the TLD for the DCVax-L trial, the stock price should easily meet the minimum required price of $3 or $4 to uplist.

NWBio should be able to submit their application to uplist soon. Donohoe Advisory Associates has extensive experience helping companies uplist from the OTC to either the NYSE, NASDAQ or AMEX.